Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 May 15, 2024
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update May 15, 2024
Be Biopharma Announces New Preclinical Data for Novel B Cell Medicine for the Potential Treatment of Hypophosphatasia May 13, 2024
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors May 10, 2024
BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline May 3, 2024
